Literature DB >> 12076881

Acute cholestatic hepatitis after reinitiating treatment with atorvastatin.

Ezequiel Ridruejo, Oscar G Mandó.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12076881     DOI： 10.1016/s0168-8278(02)00092-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

1.  Effects of statins on cholestasis: good, bad or indifferent?

Authors:  Rahul Kuver
Journal:  J Gastroenterol Hepatol       Date:  2011-10       Impact factor: 4.029

2.  Statin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of oman.

Authors:  Jimmy Jose; Faisal Abdullah Ali Al-Tamimi; Manal Mahmoud Helal; Beena Jimmy; Qasim Al Riyami
Journal:  Oman Med J       Date:  2014-09

3.  Atorvastatin-induced prolonged cholestasis with bile duct damage.

Authors:  Manuela Merli; Maria Consiglia Bragazzi; Federica Giubilo; Francesco Callea; Adolfo F Attili; Domenico Alvaro
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 4.  Statin-induced Liver Injury Patterns: A Clinical Review.

Authors:  Leon D Averbukh; Alla Turshudzhyan; David C Wu; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2022-01-10

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

6.  Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.

Authors:  Mark W Russo; Jay H Hoofnagle; Jiezhun Gu; Robert J Fontana; Huiman Barnhart; David E Kleiner; Naga Chalasani; Herbert L Bonkovsky
Journal:  Hepatology       Date:  2014-05-13       Impact factor: 17.425

7.  miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity.

Authors:  Ryan M Allen; Tyler J Marquart; Carolyn J Albert; Frederick J Suchy; David Q-H Wang; Meenakshisundaram Ananthanarayanan; David A Ford; Angel Baldán
Journal:  EMBO Mol Med       Date:  2012-07-05       Impact factor: 12.137

8.  High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort.

Authors:  Alan T Clarke; Paul C D Johnson; Gillian C Hall; Ian Ford; Peter R Mills
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.